These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7795167)
41. Cervical cancer prevention for all the world's women: genuine promise resides in skilled quality management rather than novel screening approaches. Suba EJ; Donnelly AD; Furia LM; Huynh ML; Raab SS; Diagn Cytopathol; 2007 Mar; 35(3):187-91. PubMed ID: 17304532 [TBL] [Abstract][Full Text] [Related]
42. [Cervical cancer screening in Switzerland - current practice and future challenges]. Untiet S; Schmidt N; Low N; Petignat P Ther Umsch; 2013 Apr; 70(4):223-30. PubMed ID: 23535549 [TBL] [Abstract][Full Text] [Related]
43. Cervical cancer vaccine prospects. World Health Forum; 1994; 15(4):417. PubMed ID: 7999245 [No Abstract] [Full Text] [Related]
44. Knowledge, attitudes and practices of rural women in South Africa regarding the Pap smear. Lartey M; Joubert G; Cronje HS Int J Gynaecol Obstet; 2003 Dec; 83(3):315-6. PubMed ID: 14643048 [No Abstract] [Full Text] [Related]
45. Systems analysis of real-world obstacles to successful cervical cancer prevention in developing countries. Suba EJ; Murphy SK; Donnelly AD; Furia LM; Huynh ML; Raab SS Am J Public Health; 2006 Mar; 96(3):480-7. PubMed ID: 16449592 [TBL] [Abstract][Full Text] [Related]
46. Evaluation of a hospital based cytology screening programme for reduction in life time risk of cervical cancer. Agarwal SS; Murthy NS; Sharma S; Sharma KC; Das DK Neoplasma; 1995; 42(2):93-6. PubMed ID: 7617084 [TBL] [Abstract][Full Text] [Related]
48. Crossing the quality chasm: a requirement for successful cervical cancer prevention in developing countries. Suba EJ Clin Lab Med; 2004 Dec; 24(4):945-63. PubMed ID: 15555750 [TBL] [Abstract][Full Text] [Related]
49. Papanicolaou screening in developing countries: an idea whose time has come. Suba EJ; Raab SS; Am J Clin Pathol; 2004 Mar; 121(3):315-20. PubMed ID: 15023034 [TBL] [Abstract][Full Text] [Related]
50. Comment on "New paradigm for prevention of cervical cancer" [Eur J Obstet Gynecol Reprod Biol 2007;130(1):25-9]. Mahajan NN; Gaikwad NL; Soni RN; Mahajan KN Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):140-1; author reply 141. PubMed ID: 17524549 [No Abstract] [Full Text] [Related]
51. Chapter 8: Screening for cervical cancer in developing countries. Denny L; Quinn M; Sankaranarayanan R Vaccine; 2006 Aug; 24 Suppl 3():S3/71-7. PubMed ID: 16950020 [TBL] [Abstract][Full Text] [Related]
52. [Prophylaxis and screening of precancer and cancer of the uterine cervix in the XXI century]. Kostova P; Zlatkov V Akush Ginekol (Sofiia); 2009; 48(1):41-5. PubMed ID: 19496464 [TBL] [Abstract][Full Text] [Related]
53. Cervical cancer screening in north-east Scotland. Macgregor JE; Moss S; Parkin DM; Day NE IARC Sci Publ; 1986; (76):25-36. PubMed ID: 3570409 [No Abstract] [Full Text] [Related]
54. Assessing the HPV vaccine: researchers confront complex interplay of factors. Tuma RS J Natl Cancer Inst; 2009 Apr; 101(7):444-5. PubMed ID: 19318636 [No Abstract] [Full Text] [Related]
55. [Model program for the prevention and detection of gynecologic cancer in developing countries]. Goes JS; Goes JC Bol Oficina Sanit Panam; 1980 Nov; 89(5):397-408. PubMed ID: 6452131 [No Abstract] [Full Text] [Related]